GRAIL to Present at TD Cowen 45th Annual Health Care Conference

Rhea-AI Summary

GRAIL (Nasdaq: GRAL), a healthcare company focused on early cancer detection, has announced its participation in the TD Cowen 45th Annual Health Care Conference. The company's management will deliver a presentation in Boston on Tuesday, March 4, 2025, at 9:10 a.m. ET.

Interested parties can access both live and replay webcasts through the investor relations section of GRAIL's website at investors.grail.com. The presentation recording will remain available for replay for a minimum of 30 days following the event.

News Market Reaction – GRAL

-14.72%

-14.72% Session move

In the trading session that priced this news, GRAL declined 14.72%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MENLO PARK, Calif., Feb. 21, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the TD Cowen 45th Annual Health Care Conference in Boston on Tuesday, Mar. 4 at 9:10 a.m. ET. 

Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.
For more information, visit grail.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-td-cowen-45th-annual-health-care-conference-302381977.html

SOURCE GRAIL, Inc.

FAQ

When is GRAIL (GRAL) presenting at the TD Cowen Healthcare Conference 2025?

GRAIL (GRAL) is scheduled to present at the TD Cowen Healthcare Conference on Tuesday, March 4, 2025, at 9:10 a.m. ET in Boston.

How can investors watch GRAIL's presentation at the TD Cowen Conference?

Investors can watch the presentation through live and replay webcasts available in the investor relations section of GRAIL's website at investors.grail.com.

How long will GRAIL's TD Cowen Conference presentation replay be available?

The webcast replay will be archived and available for at least 30 days after the event on GRAIL's investor relations website.

What is the focus of GRAIL's (GRAL) business mission?

GRAIL's mission is to detect cancer early when it can be cured, operating as a healthcare company focused on early cancer detection.